Susquehanna International Group, LLP Athenex, Inc. Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $0.21 $5,292 - $9,261	44,102 New	44,102 $6,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $0.91 $63,533 - $141,013	154,960 Added 748.56%	175,661 $72,000
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $84,354 - $169,777	-106,778 Reduced 83.76%	20,701 $17,000
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $123,103 - $266,119	-90,517 Reduced 41.52%	127,479 $173,000
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $745,324 - $1.21 Million	-250,951 Reduced 53.51%	217,996 $656,000
Q2 2021 Aug 11, 2021	SELL	$3.71 - $5.13 $746,804 - $1.03 Million	-201,295 Reduced 30.03%	468,947 $2.17 Million
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $2.1 Million - $7.58 Million	513,604 Added 327.89%	670,242 $2.88 Million
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $1.05 Million - $1.33 Million	94,588 Added 152.44%	156,638 $1.73 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $164,908 - $233,862	16,073 Added 34.96%	62,050 $751,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $267,094 - $516,908	-37,566 Reduced 44.97%	45,977 $633,000
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $155,294 - $431,072	-27,197 Reduced 24.56%	83,543 $647,000
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $336,201 - $621,622	35,021 Added 46.25%	110,740 $1.69 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $530,917 - $916,881	43,661 Added 136.19%	75,719 $921,000
Q2 2019 Aug 16, 2019	BUY	$9.44 - $19.8 $302,627 - $634,748	32,058 New	32,058 $635,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.